2017
Geographical differences in survival of dogs with non‐Hodgkin lymphoma treated with a CHOP based chemotherapy protocol
Wilson‐Robles H, Budke C, Miller T, Dervisis N, Novosad A, Wright Z, Thamm D, Vickery K, Burgess K, Childress M, Lori J, Saba C, Rau S, Silver M, Post G, Reeds K, Gillings S, Schleis S, Stein T, Brugmann B, DeRegis C, Smrkovski O, Lawrence J, Laver T. Geographical differences in survival of dogs with non‐Hodgkin lymphoma treated with a CHOP based chemotherapy protocol. Veterinary And Comparative Oncology 2017, 15: 1564-1571. PMID: 28419683, DOI: 10.1111/vco.12302.Peer-Reviewed Original ResearchConceptsProgression-free survivalFree survivalMultivariable Cox regression modelsShorter progression-free survivalSurvival of dogsCox regression modelNon-Hodgkin lymphomaCHOP chemotherapyChemotherapy protocolsReferral institutionMedical recordsUnivariate analysisDoxorubicin dosesCanine lymphomaVeterinary oncologyDoxorubicin treatmentGeographical differencesLymphomaDogsSignificant differencesImmunophenotypeSurvivalRegression modelsGeographic differencesUS regions
2011
Single‐agent gemcitabine chemotherapy in dogs with hepatocellular carcinomas
Elpiner A, Brodsky E, Hazzah T, Post G. Single‐agent gemcitabine chemotherapy in dogs with hepatocellular carcinomas. Veterinary And Comparative Oncology 2011, 9: 260-268. PMID: 22077406, DOI: 10.1111/j.1476-5829.2011.00262.x.Peer-Reviewed Original ResearchConceptsHepatocellular carcinomaGemcitabine chemotherapyMedian progression-free intervalSingle-agent gemcitabine chemotherapyGrade III neutropeniaNonresectable hepatocellular carcinomaSerial abdominal ultrasoundsTolerability of gemcitabineProgression-free intervalMedian survival timeAbdominal ultrasoundIncomplete resectionFree intervalSurvival timeDogsBest treatmentChemotherapyGemcitabineCarcinomaToxicityDaysVomitingNeutropeniaTolerabilityResection
2003
Gastrointestinal Leiomyosarcoma in 14 Dogs
Cohen M, Post G, Wright J. Gastrointestinal Leiomyosarcoma in 14 Dogs. Journal Of Veterinary Internal Medicine 2003, 17: 107-110. PMID: 12564735, DOI: 10.1111/j.1939-1676.2003.tb01331.x.Peer-Reviewed Original ResearchMeSH KeywordsAgingAnimalsDog DiseasesDogsFemaleGastrointestinal NeoplasmsIntestinal PerforationLeiomyosarcomaMaleNeoplasm MetastasisSurvival AnalysisConceptsImmediate postoperative periodIntestinal leiomyosarcomaPostoperative periodTime of surgeryCommon clinical signsClinical characteristic featuresLong-term survivalMedian survivalRetrospective reviewSurgical excisionGastrointestinal leiomyosarcomaLonger survivalClinical signsMean survivalSurvival rateLeiomyosarcomaDogsSurvivalSurgeryMonthsPolyuriaHypoglycemiaPolydipsiaAnemiaMetastasis